Sporadic Creutzfeldt-Jakob disease in adults over 80 years: a 10-year review of United Kingdom surveillance
Age and Ageing · 2024
DOI: 10.1093/ageing/afae086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Age and Ageing, 2024. Verfasst von Eugene Ace McDermott und 10 weiteren Autor:innen. Beteiligte Einrichtung: The National CJD Research & Surveillance Unit, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Creutzfeldt-Jakob Syndrome, Age of Onset. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health and Social Care Policy Research Programme, Scottish Government.
Abstract (Originalsprache)
Introduction
Sporadic Creutzfeldt-Jakob disease (sCJD) is a rapidly progressive neurodegenerative disease with public health implications. Mean age of onset is 68 years. Age-specific incidence declines after 80 years. This may arise from under-ascertainment or other biological features of the disease. Accurate characterisation of late-onset sCJD is important for early diagnosis, avoiding unnecessary investigations and improving ascertainment for public health purposes.
Objective
To phenotype the clinical features and investigation profile of sCJD in adults >80 years.
Methods
We analysed all probable and definite sCJD cases identified by the UK National CJD Research & Surveillance Unit over a 10-year period (2011–2021). Individuals were grouped by age of onset. Clinical features and investigation profiles were compared.
Results
10.3% (123/1196) had an age of onset over 80. Median survival was shorter (3.2 vs 4.3 months; P < 0.001). Pyramidal signs (48.3% vs 34.2%; P = 0.008) and akinetic mutism (55.1% vs 33.2%; P < 0.001) were more frequent. Psychiatric symptoms (26.3% vs 39.6%; P = 0.01) and cerebellar signs (65.4% vs 78.6%, P = 0.007) were less frequent. Cognitive impairment and myoclonus were highly prevalent regardless of age. Between age groups, the diagnostic sensitivity of cerebrospinal fluid real-time quaking-induced conversion (CSF RT-QuIC) (92.9% vs 91.9%, P = 0.74) was comparable, electroencephalography was superior (41.5% vs 25.4%; P = 0.006) and MRI was inferior (67.8% vs 91.4%; P < 0.001).
Conclusions
Late-onset sCJD has distinct clinical features, shorter survival and a different profile of investigation sensitivity. CSF RT-QuIC, MRI brain and specialist CJD review is recommended in older adults with a rapidly progressive neurological disorder. Autopsy is valuable when the cause remains elusive.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The National CJD Research & Surveillance Unit, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Förderung
- Department of Health and Social Care Policy Research Programme
- Scottish Government
Zitieren
APA
McDermott, E. A., Watson, N., Tam, J., Centola, J., Kurucu King, H., Mackenzie, J., Summers, D., Green, A., Barria, M. A., Smith, C., & Pal, S. (2024). Sporadic Creutzfeldt-Jakob disease in adults over 80 years: a 10-year review of United Kingdom surveillance. Age and Ageing. https://doi.org/10.1093/ageing/afae086
Vancouver
McDermott EA, Watson N, Tam J, Centola J, Kurucu King H, Mackenzie J, et al. Sporadic Creutzfeldt-Jakob disease in adults over 80 years: a 10-year review of United Kingdom surveillance. Age and Ageing. 2024. doi:10.1093/ageing/afae086
BibTeX
@article{McDermott2024,
author = {McDermott, Eugene Ace and Watson, Neil and Tam, Johnny and Centola, John and Kurucu King, Hatice and Mackenzie, Jan and Summers, David and Green, Alison and Barria, Marcelo A and Smith, Colin and Pal, Suvankar},
title = {Sporadic Creutzfeldt-Jakob disease in adults over 80 years: a 10-year review of United Kingdom surveillance},
journal = {Age and Ageing},
year = {2024},
doi = {10.1093/ageing/afae086}
}
EUVIMED